Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
Nancy L. Bartlett, Robert Chen, Michelle A. Fanale, Pauline Brice, Ajay Gopal, Scott E. Smith, Ranjana Advani, Jeffrey V. Matous, Radhakrishnan Ramchandren, Joseph D. Rosenblatt, Dirk Huebner, Pamela Levine, Laurie Grove, Andres Forero-Torres
Dive into the research topics of 'Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies'. Together they form a unique fingerprint.